| Epigenetic balance of gene expression by Polycomb and COMPASS families A Piunti, A Shilatifard Science 352 (6290), aad9780, 2016 | 517 | 2016 |
| Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas A Piunti, R Hashizume, MA Morgan, ET Bartom, CM Horbinski, ... Nature medicine 23 (4), 493-500, 2017 | 406 | 2017 |
| The roles of Polycomb repressive complexes in mammalian development and cancer A Piunti, A Shilatifard Nature reviews Molecular cell biology 22 (5), 326-345, 2021 | 323 | 2021 |
| Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability R Rickels, HM Herz, CC Sze, K Cao, MA Morgan, CK Collings, M Gause, ... Nature genetics 49 (11), 1647-1653, 2017 | 222 | 2017 |
| Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma TY Huang, A Piunti, RR Lulla, J Qi, CM Horbinski, T Tomita, CD James, ... Acta neuropathologica communications 5, 1-12, 2017 | 185 | 2017 |
| Polycomb complex PRC1 preserves intestinal stem cell identity by sustaining Wnt/β-catenin transcriptional activity F Chiacchiera, A Rossi, SG Jammula, A Piunti, A Scelfo, ... Cell stem cell 18 (1), 91-103, 2016 | 124 | 2016 |
| TET2 coactivates gene expression through demethylation of enhancers L Wang, PA Ozark, ER Smith, Z Zhao, SA Marshall, EJ Rendleman, ... Science advances 4 (11), eaau6986, 2018 | 118 | 2018 |
| CATACOMB: An endogenous inducible gene that antagonizes H3K27 methylation activity of Polycomb repressive complex 2 via an H3K27M-like mechanism A Piunti, ER Smith, MAJ Morgan, M Ugarenko, N Khaltyan, KA Helmin, ... Science advances 5 (7), eaax2887, 2019 | 103 | 2019 |
| Uncoupling histone H3K4 trimethylation from developmental gene expression via an equilibrium of COMPASS, Polycomb and DNA methylation D Douillet, CC Sze, C Ryan, A Piunti, AP Shah, M Ugarenko, SA Marshall, ... Nature genetics 52 (6), 615-625, 2020 | 98 | 2020 |
| Polycomb proteins control proliferation and transformation independently of cell cycle checkpoints by regulating DNA replication A Piunti, A Rossi, A Cerutti, M Albert, S Jammula, A Scelfo, L Cedrone, ... Nature communications 5 (1), 3649, 2014 | 97 | 2014 |
| Epigenetic factors in cancer development: polycomb group proteins A Piunti, D Pasini Future oncology 7 (1), 57-75, 2011 | 97 | 2011 |
| An evolutionary conserved epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS R Rickels, D Hu, CK Collings, AR Woodfin, A Piunti, M Mohan, HM Herz, ... Molecular cell 63 (2), 318-328, 2016 | 78 | 2016 |
| The controversial role of the Polycomb group proteins in transcription and cancer: how much do we not understand Polycomb proteins? A Scelfo, A Piunti, D Pasini The FEBS journal 282 (9), 1703-1722, 2015 | 75 | 2015 |
| Radiosensitization by histone H3 demethylase inhibition in diffuse intrinsic pontine glioma H Katagi, N Louis, D Unruh, T Sasaki, X He, A Zhang, Q Ma, A Piunti, ... Clinical cancer research 25 (18), 5572-5583, 2019 | 74 | 2019 |
| A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation MAJ Morgan, RA Rickels, CK Collings, X He, K Cao, HM Herz, ... Genes & development 31 (19), 2003-2014, 2017 | 71 | 2017 |
| PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes M Ponente, L Campanini, R Cuttano, A Piunti, GA Delledonne, N Coltella, ... JCI insight 2 (4), 2017 | 57 | 2017 |
| Isolation of chromatin from dysfunctional telomeres reveals an important role for Ring1b in NHEJ-mediated chromosome fusions C Bartocci, JK Diedrich, I Ouzounov, J Li, A Piunti, D Pasini, JR Yates, ... Cell reports 7 (4), 1320-1332, 2014 | 57 | 2014 |
| Decoding the protein composition of whole nucleosomes with Nuc-MS LF Schachner, K Jooß, MA Morgan, A Piunti, MJ Meiners, JO Kafader, ... Nature methods 18 (3), 303-308, 2021 | 42 | 2021 |
| Epigenetic methylations and their connections with metabolism F Chiacchiera, A Piunti, D Pasini Cellular and Molecular Life Sciences 70, 1495-1508, 2013 | 34 | 2013 |
| Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma A Piunti, K Meghani, Y Yu, AG Robertson, JR Podojil, KA McLaughlin, ... Science advances 8 (40), eabo8043, 2022 | 25 | 2022 |